Tuesday, 15 June 2021, 11:13 am
An innovative world-first Hip Fracture Registry
Toolbox has been launched today (Tuesday, June 15, 2021) to
address the alarming death and disability caused by the more
than 1 million hip fractures sustained in the Asia Pacific
each year.(1)
Developed by the Asia
Pacific Fragility Fracture Alliance (APFFA) in collaboration
with the Fragility Fracture Network (FFN), the practical and
informative resource explains the fundamental need, and how
to best advocate for, the establishment of a national hip
fracture registry. Tailored to clinicians, hospital
administrators, healthcare systems and governments alike,
the Toolbox covers pertinent topics, including stakeholder
engagement and consolidation, building a case for change,
World-first Hip Fracture Registry Toolbox striving to improve care for the 1 million+ who fracture a hip in Asia Pacific each year asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.
First approval of a conjugate vaccine that helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia, 1,2,3,4,5,6,7 including seven responsible for 40% of pneumococcal disease cases and deaths in the U.S. Helps protect against more serotypes of pneumococcal disease than any other conjugate vaccine Builds on Pfizer’s more than 20-year legacy and innovation in .
4
1PEDEGO Research Unit, Medical Research Center Oulu, Department of Obstetrics and Gynecology, Oulu University Hospital and University of Oulu, Oulu, Finland
2Cancer and Translational Medicine Research Unit, Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland
3Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland
4Department of Oncology, University of Helsinki and Helsinki University Comprehensive Cancer Center, Helsinki, Finland
Preclinical studies have suggested statins have antiproliferative and anti-metastatic effects on endometrial cancer cells. Similarly, most previous epidemiological studies have reported a better prognosis of endometrial cancer in patients who used statins. In this study, we explored the role of statins in the prognosis of endometrial cancer in women with type 2 diabetes in a hospital-based cohort. This retrospective cohort consisted of 119 women with type 2 diabetes who were
53 a team-based approach was used to deliver a medication adherence intervention; a group of experts from cardiology, nursing, community medicine, and fine arts developed and validated an intervention package that consisted of a booklet for nurses, a patient education booklet and flashcards for patient education. After one year of follow-up, the mean adherence scores were significantly higher in the intervention group (
p